A slight reduction in fasting insulin and HbA1c was observed, though these changes did not reach statistical significance ( Figure 7 A; SMD: −0.194, 95%CI=−0.332 to −0.056; I2 =39.386%, p =0.022) and ( Figure 7 B; SMD: −0.151, 95%CI=−0.294 to −0.009; I2 =17.400%, p =0.254), respectively.
← all excerpts
Resveratrol Supplementation and its Potential Benefits in Obesity-related Non-communicable Diseases.
1
0.0220
0.0220